Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > Portugal & Spain

Find below news from the Portugal and Spain. Listed are news about these countries as well as from organisations located there.

Total search results: 405 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Almirall S.A.. (10/23/12). "Press Release: Almirall Invests in Personalised Medicine by Becoming Part of the Share Capital of AB-Biotics". Barcelona. 2012-10-23
Sygnis Pharma AG. (10/18/12). "Press Release: Annual General Meeting of Sygnis Pharma AG Approves Combination of Businesses with X-Pol Biotech. Comprehensive Strategic Realignment Agreed – Election of New Supervisory Board". Heidelberg. 2012-10-18
Ability Pharmaceuticals S.L.. (9/21/12). "Press Release: AB-Therapeutics Closes 1 Million Euro Financing Round and Changes the Company Name to Ability Pharmaceuticals". Bellaterra (Barcelona). 2012-09-21
Grifols S.A.. (9/19/12). "Press Release: Grifols' Alzheimer Research Strategy Addresses the Degenerative Disease from a Global Perspective". Barcelona. 2012-09-19
Inveready Seed Capital SCR S.A.. (9/14/12). "Press Release: Sodena, Caja Navarra, Inveready and Digna Biotech Have Created ForMune". 2012-09-14
TiGenix N.V.. (8/23/12). "Press Release: TiGenix Financial Half-year Results 2012". 2012-08-23
Sygnis Pharma AG. (8/14/12). "Press Release: Sygnis Announces Three Months Results for Fiscal Year 2012/2013". Heidelberg. 2012-08-14
Almirall S.A.. (7/30/12). "Press Release: Almirall’s H1. Strong Newsflow and Guidance Reiterated". Barcelona. 2012-07-30
Myriad Genetics, Inc.. (7/26/12). "Press Release: Myriad Genetics and Pharma Mar Enter into Companion Diagnostic Agreement. Myriad Will Assess BRCA Status in Phase II Study". Salt Lake City, UT. 2012-07-26
Sygnis Pharma AG. (7/25/12). "Press Release: Sygnis Reports Financial Results for Fiscal Year 2011/12. Strategic Realignment Successfully Initiated". Heidelberg. 2012-07-25
Zeltia S.A.. (7/23/12). "Press Release: Report at 30 June 2012. 1H12 Highlights". Madrid. 2012-07-23
Sygnis Pharma AG. (7/18/12). "Press Release: Sygnis and Genetrix Announce Proposed Combination of Businesses of Sygnis and Genetrix’ Subsidiary X-Pol". Heidelberg. 2012-07-18
Genetrix S.L.. (7/16/12). "Press Release: Genetrix Licenses »Qualiphi« Polymerase to Qiagen. Genetrix’s First Global License Agreement". Madrid. 2012-07-16
Grifols S.A.. (7/11/12). "Press Release: Grifols Acquires 40% of the Capital of Biotechnology Firm VCN Bioscience". Barcelona. 2012-07-11
VCN Biosciences SL. (7/9/12). "Press Release: Grifols Acquires 40% of the Capital of Biotechnology Firm VCN Bioscience. The Group’s Investment Will Ensure the Viability of Research Projects in the Field of Oncology". Barcelona. 2012-07-09
Zeltia S.A.. (7/2/12). "Press Release: Zeltia Announces that Subsidiary PharmaMar Is Commencing a Phase II Trial with PM01183 in Patients with Breast Cancer". Madrid. 2012-07-02
Zeltia S.A.. (6/29/12). "Press Release: Zeltia Receives 9.5 Million Euro from the Spanish Public Administrations for the Payment of Outstanding Invoices". Madrid. 2012-06-29
IRB Barcelona. (6/28/12). "Press Release: Ysios Capital Leads a Two Million Euros Investment in Inbiomotion". 2012-06-28
IRB Barcelona. (6/27/12). "Press Release: Two IRB Barcelona Projects on Rare Diseases Receive Funding from the Fundación Ramon Areces. In the Framework of the XVI National Call for Scientific and Technical Research Funding 2011, in the Life Sciences Sect 2012-06-27
Accovion GmbH. (6/22/12). "Press Release: Accovion GmbH further Expands Global Presence. Accovion Launches New Subsidiary in Spain". Eschborn. 2012-06-22
Inveready Seed Capital SCR S.A.. (6/14/12). "Press Release: Inveready and Fitalent Have Invested € 1 Million in PaloBiofarma". 2012-06-14
Fundacíon MEDINA. (6/11/12). "Press Release: Fundacíon MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals, Inc.". Granada. 2012-06-11
Ysios Capital Partners. (05/29/2012). "Press Release: Cristina Garmendia Returns to Ysios Capital as Partner". Barcelona. 2012-05-29
AiCuris GmbH & Co. KG. (4/2/12). "Press Release: Results of Letermovir (AIC246) Phase 2b in Prophylaxis of Human Cytomegalovirus in Recipients of Human Blood Precursor Cell Transplants Meeting both Primary Efficacy Endpoints to Be Presented at Internatio 2012-04-02
Biofrontera AG. (3/29/12). "Press Release: Biofrontera and Allergan Sign Marketing and Distribution Agreement for Ameluz in Spain". Leverkusen. 2012-03-29
Biocat. (3/20/12). "Press Release: Barcelona to Host BIO-Europe Spring, Top European Biotechnology Congress, again in 2013". 2012-03-20
Biocat. (3/20/12). "Press Release: Salvador Maluquer, New General Director of Barcelona Science Park". 2012-03-20
Grifols S.A.. (3/15/12). "Press Release: Grifols Has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects. Alzheimer’s Disease Acquires a Growing Role in Grifols R&D". Barcelona. 2012-03-15
Boehringer Ingelheim. (3/2/12). "Press Release: Porcine Circovirus Research Projects from France and Spain Awarded". Ingelheim. 2012-03-02
AB-Biotics S.A.. (2/28/12). "Press Release: AB-Biotics Sign Licensing Agreements on Cholesterol-lowering Probiotic for Southeast Europe and Spain". 2012-02-28
2B BlackBio S.L.. (2/27/12). "Press Release: The Spanish Biotechnological Companies, Biotools and 2B BlackBio, Reach an Agreement with the Mexican Pharmaceutics Silanes Laboratories". 2012-02-27
Inveready Seed Capital SCR S.A.. (2/16/12). "Press Release: The Firm from Navarra Bionanoplus Has Developed a New Technology that Opens a New Way in the History of the Nanotechnology. Its Applications Go from Agriculture to Food". Pamplona. 2012-02-16
4DCell Fate Project. (2/13/12). "Press Release: Cell Fate in 4D. Bringing together European Excellence to Uncover the Mechanisms at Work that Determine Cell Fate". Barcelona. 2012-02-13
Ferrer. (2/9/12). "Press Release: Ferrer Announces Best-in-Class Results in Phase I for Lorediplon in Insomnia. Ferrer Now Seeking Development Partners for Lorediplon". Barcelona. 2012-02-09
Biocrates Life Sciences AG. (2/6/12). "Press Release: Biocrates Goes Spain and Turkey. Austrian Diagnostic Expert in Personalized Medicine Coninues to Expand Its European Distribution Network". 2012-02-06
Almirall S.A.. (1/25/12). "Press Release: Almirall and Galapagos Enter a Research Alliance. The Three-year Integrated Drug Discovery Alliance Is for Identigying Drug Development Candidates – Collaboration Is for Treating Respiratory Disease". Barcelona. 2012-01-25
Cellartis AB. (1/23/12). "Press Release: Cellartis Is a Partner in CardioNeT, an EU-Project with the Aim to Develop Novel Therapeutic Tools for Identification of Heart Disease". Gothenburg. 2012-01-23
Archivel. (01/15/2012). "Press Release: Archivel Secures Funding to Bring the Antituberculosis Therapeutic Vaccine RUTI to Market". Barcelona. 2012-01-15
Biocat. (1/12/12). "Press Release: Intelligent Pharma Opens Subsidiary in United States. This New Subsidiary, Based in Cambridge (Massachusetts), Is the Third International Office This Biotech Company Has Opened in Less than Two years". 2012-01-12
Centre for Genomic Regulation (CRG). (12/11/11). "Press Release: BioPreDyn Project. Computational Modelling for Biotechnology – Predictions for Optimal Production". Barcelona. 2011-12-11
Almirall S.A.. (12/5/11). "Press Release: Almirall Launches Solaraze in Spain for the Treatment of Actinic Keratosis". Barcelona. 2011-12-05
Ysios Capital Partners. (12/01/2011). "Press Release: Ysios Capital Partners and “la Caixa” Lead MedLumics €3.5million/$4.7million Series A Financing". Madrid. 2011-12-01
Wilex AG. (11/21/11). "Press Release: Wilex AG. ARISER Independent Data Monitoring Committee (IDMC) Recommends Conducting the Final Analysis of the Pivotal Phase III Trial with Rencarex". Munich. 2011-11-21
Almirall S.A.. (11/16/11). "Press Release: Almirall Starts Phase III for Aclidinium and Formoterol in COPD. Almirall’s Respiratory Franchise Continues to Expand in COPD". Barcelona. 2011-11-16
Almirall S.A.. (11/15/11). "Press Release: Almirall and BioFocus Announce Collaboration to Find New Hit Compounds against Key Targets. Targets Are Related to the Treatment of Respiratory and Inflammatory Conditions". Barcelona & Saffron Walden. 2011-11-15
Galenica Holding AG. (11/15/11). "Press Release: Galenica Strengthens Its Market Position in Spain. It Acquires All Shares of Vifor Uriach Pharma as Well as Grupo Uriach’s Primary Care Business". 2011-11-15
PerkinElmer, Inc.. (11/11/11). "Press Release: PerkinElmer to Showcase Innovative Analytical Solutions at Expoquimia 2011". Waltham, MA. 2011-11-11
Biocat. (11/8/11). "Press Release: Bilbao, Will Be the Venue for Biospain 2012. Biospain Is the Presentation Platform for the Spanish Biotechnology at an International Level". 2011-11-08
2B BlackBio S.L.. (10/25/11). "Press Release: BlackBio Gets more than 2 Million Euros after Capital Increase and Public Funding". 2011-10-25
Lipopharma Therapeutics S.L.. (10/21/11). "Press Release: EMA’s COMP Grants Orphan Medicinal Product Designation to Lipopharma’s Minerval for the Treatment of Glioma". Palma de Mallorca. 2011-10-21
IRB Barcelona. (10/3/11). "Press Release: IRB Barcelona Spin-off to Develop a Diagnostic Kit and New Treatments for Metastasis". Barcelona. 2011-10-03
Nycomed. (9/29/11). "Press Release: Nycomed and Almirall Announce a Licensing Agreement for Ebastine in China and other Key Southeast Asia Markets". 2011-09-29
Hypha Disovery Ltd.. (9/27/11). "Press Release: Hypha Discovery Signs Natural Products Drug Discovery Collaboration with Ferrer Grupo". London. 2011-09-27
Advancell. (19.09.2011). "Press Release: Start of In-patient Clinical Trials with NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis without Immunosuppressive Effects". Barcelona. 2011-09-19
AM-Pharma B.V.. (9/13/11). "Press Release: AM-Pharma Raises €29.2m in Series D Financing". Bunnik. 2011-09-13
Ysios Capital Partners. (09/13/2011). "Press Release: Ysios Capital Partners Leads €29.2million Series D Financing of AM-Pharma". Barcelona. 2011-09-13
Biocat. (8/29/11). "Press Release: AB-Biotics Starts Up Expansion Plan for United States, Europe and Latin America. This Biotech Company Is Preparing a Capital Increase to Fund Their Positioning Abroad". 2011-08-29
Pharming Group N.V.. (8/29/11). "Press Release: Pharming Grants SOBI Additional Territories for the Commercialisation of Ruconest". Leiden. 2011-08-29
Halo Genomics AB. (7/27/11). "Press Release: Genycell Biotech Appointed as Distributor in Spain & Portugal". Uppsala. 2011-07-27
GW Pharmaceuticals plc. (7/4/11). "Press Release: Sativex Launched in Germany". Porton Down. 2011-07-04
Bruker Corporation. (6/27/11). "Press Release: Bruker and Francisco Soria Melguizo S.A. Expand Their Exclusive Agreement for Distribution of the MALDI Biotyper to Cover Spain and Portugal". Geneva. 2011-06-27
4SC AG. (6/23/11). "Press Release: 4SC Reports New Data from the Clinical Trials with Oral Pan-HDAC Inhibitor Resminostat. Update on Phase II SHELTER and Phase I/II SHORE Trials". Planegg-Martinsried. 2011-06-23
Biocat. (6/10/11). "Press Release: Intelligent Pharma Opens Its Second Subsidiary Office in Europe. It Is Located in Hertforshire (United Kingdom) at the BioPark Cluster, Only a Year Later After the Opening of Its First International Office in Germany". 2011-06-10
Advancell. (17.05.2011). "Press Release: Advancell Announces the Initiation of a Clinical Phase IIb Study of ATH008 in Hand-Foot Syndrome (or Palmar-Plantar Erythrodysesthesia Syndrome)". Barcelona. 2011-05-17
MorphoSys AG. (5/16/11). "Press Release: AbD Serotec Licenses Seven Diagnostic HuCAL Antibodies to Proteomika to Monitor Biologic Therapies. First HuCAL-based Diagnostic Kits to Enter Market". 2011-05-16
Sabirmedical. (5/10/11). "Press Release: Dr. Oriol de Solà-Morales Joins Sabirmedical’s Management Team". Barcelona. 2011-05-10
Advancell. (03/14/2011). "Press Release: Biotech Companies Advancell, Neurotec Pharma and Aromics, Have Created the Consortium MSALS – in Order to Develop a New Treatment for Multiple Sclerosis". Barcelona. 2011-03-14
Advancell. (14.03.2011). "Press Release: Advancell and Leitat Join Forces to Promote Cell Reagents through the New Company, ReadyCell". Barcelona. 2011-03-14
Advancell. (14.03.2011). "Press Release: Advancell Announces Promising Phase I/IIa Results with Acadra in CLL". Barcelona. 2011-03-14
Probiodrug AG. (3/8/11). "Press Release: Probiodrug and Its Collaborators Will Present Novel Insights into the Pathophysiology of AD and Biomarkers at AP/PD 2011 in Barcelona". Halle (Saale). 2011-03-08
Symphogen A/S. (3/7/11). "Press Release: Symphogen Receives US Patent on Lead Cancer Compound Sym004. Sym004 Anti-cancer Activity Highlighted at Major Oncology Meeting". Paris. 2011-03-07
TiGenix N.V.. (2/25/11). "Press Release: TiGenix Announces Proposed Combination with Cellerix and Capital Increase through a Public Rights Offering. Combination Will Create the European Cell Therapy Leader with Two Marketed Products and a Promising Pipel 2011-02-25
TiGenix N.V.. (2/25/11). "Press Release: TiGenix Announces Proposed Combination with Cellerix. Presentation – Creating the European Cell Therapy Leader". Leuven & Tres Cantos. 2011-02-25
Integromics S.L.. (11/29/10). "Press Release: The Princeton Mass Spectrometry Center Purchases License for Integromics’ OmicsHub Data Management and Analysis Solution". Granada, Madrid & Philadelphia, PA. 2010-11-29
Evotec AG. (11/11/10). "Press Release: Accelerated Positive Trend on Evotec’s Revenues and Profits". Hamburg. 2010-11-11
Cenix BioScience GmbH. (11/11/10). "Press Release: Cenix BioScience and Integromics Awarded EU FP7 EuroTransBio Grant to Co-develop Integrated Data Analysis Environment for HT-RNAi Screening". Dresden. 2010-11-11
Epigenomics AG. (10/27/10). "Press Release: Epigenomics AG. New Clinical Data for Septin9 Colorectal Cancer Blood Test Presented at UEGW. Independent Validation of Laboratory Test Used in PRESEPT Study Shows that the Test Finds 86% of the Cancers". Berli 2010-10-27
Signature Diagnostics AG. (10/27/10). "Press Release: Signature Diagnostics to Present Company’s Blood-based Colorectal Cancer Screening Strategy at the 18th UEGW Congress in Barcelona. Advantages of Detector C and Dectector C/Plus in Early Detection of 2010-10-27
Epigenomics AG. (10/22/10). "Press Release: Epigenomics AG to Update on Clinical Studies with Septin9 Blood Test for Colorectal Cancer at Two Conferences in Europe and the US". Berlin & Seattle, WA. 2010-10-22
Integromics S.L.. (9/28/10). "Press Release: Integromics Appoints Dr. Michael J. McManus as President & CEO". Granada, Madrid & Philadelphia, PA. 2010-09-28
Amsterdam Molecular Therapeutics. (9/28/10). "Press Release: AMT’s Partner Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene". Amsterdam. 2010-09-28
Evotec AG. (9/23/10). "Press Release: Ion Channel Hit Identification Agreement with Almirall". Hamburg. 2010-09-23
Ysios Capital Partners. (09/21/2010). "Press Release: Ysios Capital Partners Leads €5million Series A Financing of Sabirmedical". Barcelona. 2010-09-21
Nycomed AG. (9/19/10). "Press Release: Daxas (roflumilast) Data Analysis Shows Reduction in Harmful Lung Attacks". 2010-09-19
Signature Diagnostics AG. (7/8/10). "Press Release: Signature Diagnostics Presents Positive Colorectal Screening Study Results at the 12th World Congress on Gastrointestinal Cancer in Barcelona". Potsdam. 2010-07-08
Royal Philips Electronics. (5/31/10). "Press Release: New Clinical Study Shows Telehealth Patients Experience a Significant Improvement in Care and Quality of Life". Berlin. 2010-05-31
Argen-X B.V.. (3/1/10). "Press Release: Argen-X SIMPLE Antibody Platform Set to Transform Therapeutic Antibody Discovery and Development". Rotterdam. 2010-03-01
2B BlackBio S.L.. (2/15/10). "Press Release: BlackBio, Making Personalized Medicine a Reality. Established in 2009 BlackBio Is a Biotechnology Spin-off Company Committed to Making Personalized Medicine an Affordable Reality". 2010-02-15
Roche. (11/24/09). "Press Release: Roche and the Department of Health of Junta de Andalucía Collaborate in Spanish Medical Genome Project". Penzberg. 2009-11-24
Proteros Biostructures GmbH. (9/22/11). "Press Release: Almirall Enters into Integrated Discovery Agreement with Proteros". Barcelona. 2009-11-22
Amsterdam Molecular Therapeutics. (10/29/09). "Press Release: AMT Starts Development of LPLChip with Progenika". Amsterdam. 2009-10-29
GE Healthcare. (10/11/09). "Press Release: GE Healthcare Highlights Portfolio of Molecular Imaging Innovations at European Association of Nuclear Medicine 2009". Barcelona. 2009-10-11
Ysios Capital Partners. (09/28/2009). "Press Release: Laia Crespo Joins Ysios Capital Partners as Investment Manager". Barcelona. 2009-09-28
Medigene AG. (9/9/09). "Press Release: MediGene Receives Marketing Authorization for Veregen in Germany". Martinsried. 2009-09-09
Ysios Capital Partners. (09/02/2009). "Press Release: Ysios Capital Partners Participates in the $36million . €25million Series B Financing of Endosense". Barcelona. 2009-09-02
TomTec Imaging Systems GmbH. (8/25/09). "Press Release: TomTec Launches the Vascular Analysis Solution M’Ath. TomTec Extends CardioArena Product Portfolio with a Vascular Analysis Solution". Barcelona. 2009-08-25
Medigene AG. (7/10/09). "Press Release: MediGene Receives Positive Assessment on Market Authorisation for Veregen in First European Countries". Martinsried. 2009-07-10
MorphoSys AG. (7/9/09). "Press Release: AbD Serotec and Spinreact Sign Supply Agreement for Antibodies Used in Clinical Diagnostic Kits". 2009-07-09
Roche. (7/8/09). "Press Release: The Research Institute of the Hospital Universitari Vall d’Hebron Is the First Spanish Health Centre to Acquire High-performance Sequencing Technology of 454 Life Sciences". Barcelona. 2009-07-08
Evotec AG. (7/7/09). "Press Release: Evotec-RSIL Ltd Extends Library Synthesis Collaboration with Ferrer Grupo". Thane, India. 2009-07-07
next pagenext page 1 2 3 4 5  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top